HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Picon, A Articles by de Keyzer, Y Search for Related Content PubMed PubMed Citation Articles by Picon, A Articles by de Keyzer, Y

DMS-79 is a human cell line derived from a small cell lung carcinoma (SCLC), which expresses the pro-opiomelanocortin (POMC) gene. We took it as a model in which to study the mechanism of POMC gene expression in non-pituitary tumours. DMS-79 reproduces the usual characteristics of POMC expression in these tumours: precursor processing is altered and gene expression is essentially unresponsive to glucocorticoids. POMC gene structure appeared normal by Southern blot analysis, indicating that gene rearrangement was not responsible for its expression in DMS-79. Indeed, using transient expression of human POMC—luciferase fusion genes in DMS-79, we showed that (1) the normal human POMC promoter was functional in DMS-79, and (2) the same proximal promoter region (–417;+21) produced the full transcriptional activity in DMS-79 and in the mouse pituitary cell line AtT-20. Progressive 5' deletion analysis revealed differences between AtT-20 and DMS-79: region (–161;–376) was active in AtT-20 and not in DMS-79, whereas region (–95;–161) was active in both cell lines and (–376;–417) was only active in DMS-79. The latter partially overlaps a motif homologous to the DE-2 rat element which confers the tissue-specific expression of POMC in AtT-20 cells; however, this motif had no effect in DMS-79. These data suggest that POMC gene transcription is achieved through a different set of transacting factors in DMS-79 and AtT-20. Altogether, our results provide evidence that DMS-79 is a valid model of tumours responsible for the ectopic ACTH syndrome and that the mechanism of POMC gene expression in these SCLC cells is different from that in pituitary cells.

This article has been cited by other articles:

				L. Ye, X. Li, X. Kong, W. Wang, Y. Bi, L. Hu, B. Cui, X. Li, and G. Ning Hypomethylation in the promoter region of POMC gene correlates with ectopic overexpression in thymic carcinoids J. Endocrinol., May 1, 2005; 185(2): 337 - 343. [Abstract] [Full Text] [PDF]

				Y. Ueda, S. Bandoh, J. Fujita, M. Sato, Y. Yamaji, and J. Takahara Expression of Nerve Growth Factor-Induced Clone B Subfamily and Pro-opiomelanocortin Gene in Lung Cancer Cell Lines Am. J. Respir. Cell Mol. Biol., June 1, 1999; 20(6): 1319 - 1325. [Abstract] [Full Text]

				M. Leblond-Francillard, A. Picon, X. Bertagna, and Y. de Keyzer High Expression of the POU Factor Brn3a in Aggressive Neuroendocrine Tumors J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 89 - 94. [Abstract] [Full Text] [PDF]